Cho Y, Kim S, Kim P, Jo M, Park S, Choi Y
Biomolecules. 2025; 15(2).
PMID: 40001594
PMC: 11852853.
DOI: 10.3390/biom15020291.
He X, Zhao W, Li P, Zhang Y, Li G, Su H
Front Pharmacol. 2025; 15:1483792.
PMID: 39902077
PMC: 11788294.
DOI: 10.3389/fphar.2024.1483792.
Duran M, Willis J, Dalvi N, Fokakis Z, Virkus S, Hardaway J
Endocrinology. 2025; 166(3).
PMID: 39888375
PMC: 11850305.
DOI: 10.1210/endocr/bqaf019.
Zaman V, Matzelle D, Banik N, Haque A
Cells. 2025; 14(2).
PMID: 39851552
PMC: 11764466.
DOI: 10.3390/cells14020124.
Ali A, Khan D, Dubey V, Tarasov A, Flatt P, Irwin N
Biomolecules. 2025; 14(12.
PMID: 39766228
PMC: 11673903.
DOI: 10.3390/biom14121520.
Old and new anti-obesity drugs.
Dodangeh S, Hasani-Ranjbar S
J Diabetes Metab Disord. 2024; 24(1):16.
PMID: 39712336
PMC: 11659566.
DOI: 10.1007/s40200-024-01512-5.
Recent achievements and future directions of anti-obesity medications.
Grandl G, Novikoff A, Liu X, Muller T
Lancet Reg Health Eur. 2024; 47:101100.
PMID: 39582489
PMC: 11585837.
DOI: 10.1016/j.lanepe.2024.101100.
Incretin hormones and obesity.
Alcaino C, Reimann F, Gribble F
J Physiol. 2024; .
PMID: 39576749
PMC: 7617301.
DOI: 10.1113/JP286293.
Exploring potential targets for natural product therapy of DN: the role of SUMOylation.
Wang J, Zhang R, Wu C, Wang L, Liu P, Li P
Front Pharmacol. 2024; 15:1432724.
PMID: 39431155
PMC: 11486755.
DOI: 10.3389/fphar.2024.1432724.
The discovery and development of GLP-1 based drugs that have revolutionized the treatment of obesity.
Friedman J
Proc Natl Acad Sci U S A. 2024; 121(39):e2415550121.
PMID: 39297680
PMC: 11441540.
DOI: 10.1073/pnas.2415550121.
Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen awarded Lasker prize for pioneering work on GLP-1.
Ardehali H
J Clin Invest. 2024; 134(19).
PMID: 39295302
PMC: 11446598.
DOI: 10.1172/JCI186225.
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists.
Liu Q
Front Endocrinol (Lausanne). 2024; 15:1431292.
PMID: 39114288
PMC: 11304055.
DOI: 10.3389/fendo.2024.1431292.
Enteroendocrine cells regulate intestinal homeostasis and epithelial function.
Nwako J, McCauley H
Mol Cell Endocrinol. 2024; 593:112339.
PMID: 39111616
PMC: 11401774.
DOI: 10.1016/j.mce.2024.112339.
Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases.
Himmerich H, Bentley J, McElroy S
CNS Drugs. 2024; 38(9):697-718.
PMID: 39096466
DOI: 10.1007/s40263-024-01111-1.
Glucagon-Like Peptide Receptor-1 Agonists Used for Medically-Supervised Weight Loss in Patients With Hip and Knee Osteoarthritis: Critical Considerations for the Arthroplasty Surgeon.
Heckmann N, Palmer R, Mayfield C, Gucev G, Lieberman J, Hong K
Arthroplast Today. 2024; 27:101327.
PMID: 39071832
PMC: 11282421.
DOI: 10.1016/j.artd.2024.101327.
Ketosis Suppression and Ageing (KetoSAge) Part 2: The Effect of Suppressing Ketosis on Biomarkers Associated with Ageing, HOMA-IR, Leptin, Osteocalcin, and GLP-1, in Healthy Females.
Cooper I, Kyriakidou Y, Petagine L, Edwards K, Soto-Mota A, Brookler K
Biomedicines. 2024; 12(7).
PMID: 39062126
PMC: 11274887.
DOI: 10.3390/biomedicines12071553.
Transforming obesity: The advancement of multi-receptor drugs.
Kusminski C, Perez-Tilve D, Muller T, DiMarchi R, Tschop M, Scherer P
Cell. 2024; 187(15):3829-3853.
PMID: 39059360
PMC: 11286204.
DOI: 10.1016/j.cell.2024.06.003.
Optogenetics in Pancreatic Islets: Actuators and Effects.
Gangemi C, Janovjak H
Diabetes. 2024; 73(10):1566-1582.
PMID: 38976779
PMC: 11417442.
DOI: 10.2337/db23-1022.
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects.
Riemma M, Mele E, Donniacuo M, Telesca M, Bellocchio G, Castaldo G
Front Pharmacol. 2024; 15:1422740.
PMID: 38948473
PMC: 11212466.
DOI: 10.3389/fphar.2024.1422740.
Potential Role of Phytochemicals as Glucagon-like Peptide 1 Receptor (GLP-1R) Agonists in the Treatment of Diabetes Mellitus.
Abiola J, Oluyemi A, Idowu O, Oyinloye O, Ubah C, Owolabi O
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931402
PMC: 11206448.
DOI: 10.3390/ph17060736.